Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

1.

Immunotherapy for multiple myeloma: Current status and future directions.

Ayed AO, Chang LJ, Moreb JS.

Crit Rev Oncol Hematol. 2015 Jun 28. pii: S1040-8428(15)00124-9. doi: 10.1016/j.critrevonc.2015.06.006. [Epub ahead of print] Review.

PMID:
26153389
2.

New primary malignancy masquerading as metastatic prostate adenocarcinoma.

Szwed EA, Sliesoraitis S, Nguyen TC, Nguyen MN, Moreb JS, Zlotecki RA, Crispen PL, Dang NH, Dang LH.

Case Rep Oncol Med. 2015;2015:358572. doi: 10.1155/2015/358572. Epub 2015 Feb 19.

3.

New cancers after autotransplantations for multiple myeloma.

Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN.

Biol Blood Marrow Transplant. 2015 Apr;21(4):738-45. doi: 10.1016/j.bbmt.2014.12.028. Epub 2014 Dec 31.

PMID:
25555448
4.

Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?

Pors K, Moreb JS.

Drug Discov Today. 2014 Dec;19(12):1953-63. doi: 10.1016/j.drudis.2014.09.009. Epub 2014 Sep 26. Review.

PMID:
25256776
5.

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study.

Byrne M, Salmasinia D, Leather H, Cogle CR, Davis A, Hsu JW, Wiggins L, Chang MN, An Q, Wingard JR, Moreb JS.

Clin Med Insights Oncol. 2014 Sep 3;8:101-5. doi: 10.4137/CMO.S16835. eCollection 2014.

6.

Oral squamous cell carcinoma positive for p16/human papilloma virus in post allogeneic stem cell transplantation: 2 cases and review of the literature.

Katz J, Islam MN, Bhattacharyya I, Sandow P, Moreb JS.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Sep;118(3):e74-8. doi: 10.1016/j.oooo.2014.05.025. Epub 2014 Jun 13. Review.

7.

Multiple myeloma in bisphosphonate-affected jaws--a diagnostic challenge: case report.

Katkar RA, Katz J, Moreb JS, Nair MK.

Quintessence Int. 2014 Jul-Aug;45(7):613-7. doi: 10.3290/j.qi.a31962.

PMID:
24847501
8.

Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple myeloma.

Byrne M, Wingard JR, Moreb JS.

Transplant Proc. 2013 Nov;45(9):3361-5. doi: 10.1016/j.transproceed.2013.03.054.

PMID:
24182816
9.
10.

Myxoma and vaccinia viruses bind differentially to human leukocytes.

Chan WM, Bartee EC, Moreb JS, Dower K, Connor JH, McFadden G.

J Virol. 2013 Apr;87(8):4445-60. doi: 10.1128/JVI.03488-12. Epub 2013 Feb 6.

11.

Salvage second hematopoietic cell transplantation in myeloma.

Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT, Kumar S, Lill M, Meehan KR, Saber W, Schriber J, Tay J, Vogl DT, Wirk B, Savani BN, Gale RP, Vesole DH, Schiller GJ, Abidi M, Anderson KC, Nishihori T, Kalaycio ME, Vose JM, Moreb JS, Drobyski W, Munker R, Roy V, Ghobadi A, Holland HK, Nath R, To LB, Maiolino A, Kassim AA, Giralt SA, Landau H, Schouten HC, Maziarz RT, Mikhael J, Kindwall-Keller T, Stiff PJ, Gibson J, Lonial S, Krishnan A, Dispenzieri A, Hari P; Plasma Cell Disorders Working Committee of the Center for International Blood and Marrow Transplant Research.

Biol Blood Marrow Transplant. 2013 May;19(5):760-6. doi: 10.1016/j.bbmt.2013.01.004. Epub 2013 Jan 5.

12.

Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation.

Patel ES, Okada S, Hachey K, Yang LJ, Durum SK, Moreb JS, Chang LJ.

BMC Immunol. 2012 Aug 16;13:46. doi: 10.1186/1471-2172-13-46.

13.

Lenalidomide after stem-cell transplantation for multiple myeloma.

McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C.

N Engl J Med. 2012 May 10;366(19):1770-81. doi: 10.1056/NEJMoa1114083.

14.

Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.

Bartee E, Chan WM, Moreb JS, Cogle CR, McFadden G.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1540-51. doi: 10.1016/j.bbmt.2012.04.004. Epub 2012 Apr 16.

15.

Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.

Wirk B, Wingard JR, Moreb JS.

Bone Marrow Transplant. 2013 Jan;48(1):10-8. doi: 10.1038/bmt.2012.26. Epub 2012 Mar 12. Review.

PMID:
22410751
16.
17.

Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure.

Duff JM, Moreb JS, Muwalla F.

Ann Pharmacother. 2012 Jan;46(1):e1. doi: 10.1345/aph.1Q467. Epub 2011 Dec 13.

PMID:
22170976
18.

The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.

Moreb JS, Ucar D, Han S, Amory JK, Goldstein AS, Ostmark B, Chang LJ.

Chem Biol Interact. 2012 Jan 5;195(1):52-60. doi: 10.1016/j.cbi.2011.10.007. Epub 2011 Nov 3.

19.

Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.

Katz J, Gong Y, Salmasinia D, Hou W, Burkley B, Ferreira P, Casanova O, Langaee TY, Moreb JS.

Int J Oral Maxillofac Surg. 2011 Jun;40(6):605-11. doi: 10.1016/j.ijom.2011.02.002. Epub 2011 Mar 10.

PMID:
21396799
20.

Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study.

Salmasinia D, Chang M, Wingard JR, Hou W, Moreb JS.

Clin Med Insights Oncol. 2010 Nov 16;4:117-25. doi: 10.4137/CMO.S6161.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk